Director
CurrentIMBiotechnologies Ltd., (IMB) is a privately held Canadian biotechnology company whose focus is commercializing medical device products in the area of embolotherapy*. Lead products include devices for the treatment of benign and malignant tumors, with particular focus on the treatment of Uterine Fibroids, and enlarged prostates due to benign prostatic hypertropy/hyperplasia (BPH). IMB's products are unique in their ability to target specific sites using BIODEGRADABLE materials.